| 1 |
Production and Characterization of Active Recombinant Human Factor II With Consistent Sialylation
Lee JH, Reier J, Heffner KM, Barton C, Spencer D, Schmelzer AE, Venkat R
Biotechnology and Bioengineering, 114(9), 1991, 2017 |
| 2 |
A bicistronic vector with destabilized mRNA secondary structure yields scalable higher titer expression of human neurturin in E-coli
Roy V, Roth R, Berge M, Chitta R, Vajrala S, Kuntumalla S, Schmelzer AE, Schoner R
Biotechnology and Bioengineering, 114(8), 1753, 2017 |
| 3 |
A Novel Cholesterol/Lipid Delivery System for Murine Myeloma Cell Lines
Chauhan G, Schmelzer AE
Biotechnology Progress, 33(3), 795, 2017 |
| 4 |
Effects of osmoprotectant compounds on NCAM polysialylation under hyperosmotic stress and elevated pCO(2)
Schmelzer AE, Miller WM
Biotechnology and Bioengineering, 77(4), 359, 2002 |
| 5 |
Characterization of hybridoma cell responses to elevated pCO(2) and osmolality: Intracellular pH, cell size, apoptosis, and metabolism
deZengotita VM, Schmelzer AE, Miller WM
Biotechnology and Bioengineering, 77(4), 369, 2002 |
| 6 |
Selected amino acids protect hybridoma and CHO cells from elevated carbon dioxide and osmolality
deZengotita VM, Abston LR, Schmelzer AE, Shaw S, Miller WM
Biotechnology and Bioengineering, 78(7), 741, 2002 |
| 7 |
Hyperosmotic stress and elevated pCO(2) alter monoclonal antibody charge distribution and monosaccharide content
Schmelzer AE, Miller WM
Biotechnology Progress, 18(2), 346, 2002 |
| 8 |
Considerations for osmolality measurement under elevated pCO(2): Comparison of vapor pressure and freezing point osmometry
Schmelzer AE, deZengotita VM, Miller WM
Biotechnology and Bioengineering, 67(2), 189, 2000 |
| 9 |
Bicarbonate concentration and osmolality are key determinants in the inhibition of CHO cell polysialylation under elevated pCO(2) or pH
Zanghi JA, Schmelzer AE, Mendoza TP, Knop RH, Miller WM
Biotechnology and Bioengineering, 65(2), 182, 1999 |
| 10 |
Role of nucleotide sugar pools in the inhibition of NCAM polysialylation by ammonia
Zanghi JA, Mendoza TP, Schmelzer AE, Knop RH, Miller WM
Biotechnology Progress, 14(6), 834, 1998 |
